| human | Q5 |
| P734 | family name | Owens | Q357139 |
| Owens | Q357139 | ||
| Owens | Q357139 | ||
| P735 | given name | Gary | Q1820274 |
| Gary | Q1820274 | ||
| P106 | occupation | researcher | Q1650915 |
| Q30274746 | "Attack of the Clones": Commonalities Between Cancer and Atherosclerosis |
| Q30435837 | 5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo |
| Q27342659 | 5-Lipoxygenase pathway in experimental abdominal aortic aneurysms |
| Q30434820 | A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. |
| Q30470837 | A new single-injury model of balloon angioplasty in cholesterol-fed rabbits: beneficial effect of hirudin and comparison with double-injury model |
| Q30464911 | A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics |
| Q30470269 | A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements |
| Q30311219 | A transforming growth factor-beta control element required for SM alpha-actin expression in vivo also partially mediates GKLF-dependent transcriptional repression |
| Q30434317 | ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development |
| Q30467577 | ANG II- or AVP-induced increases in protein synthesis are not dependent on autocrine secretion of PDGF-AA. |
| Q30464704 | Activated alpha 2-macroglobulin and transforming growth factor-beta 1 induce a synergistic smooth muscle cell proliferative response |
| Q30276803 | Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective |
| Q30412759 | Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysms |
| Q56883827 | All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit : a favorable effect on vessel remodeling |
| Q30462210 | Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells |
| Q30467802 | Angiotensin II stimulates increased protein synthesis, not increased DNA synthesis, in intact rat aortic segments, in vitro |
| Q30464081 | Angiotensin II-induced hypertrophy of rat vascular smooth muscle is associated with increased 18 S rRNA synthesis and phosphorylation of the rRNA transcription factor, upstream binding factor |
| Q30434958 | Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta |
| Q30471070 | Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox |
| Q30469807 | Arterial thrombin activity after angioplasty in an atherosclerotic rabbit model: time course and effect of hirudin |
| Q30440172 | Assessment of contractility of purified smooth muscle cells derived from embryonic stem cells. |
| Q30419933 | Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation |
| Q30434254 | Bone marrow-derived cell-specific chemokine (C-C motif) receptor-2 expression is required for arteriolar remodeling |
| Q30307166 | CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo |
| Q47724846 | Cigarette Smoke Initiates Oxidative Stress-Induced Cellular Phenotypic Modulation Leading to Cerebral Aneurysm Pathogenesis |
| Q30417628 | Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease |
| Q96429533 | Clonally expanding smooth muscle cells promote atherosclerosis by escaping efferocytosis and activating the complement cascade |
| Q30310837 | Combinatorial Control of Smooth Muscle–Specific Gene Expression |
| Q30441798 | Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells |
| Q30440313 | Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury |
| Q30442507 | Conditional mouse models to study developmental and pathophysiological gene function in muscle. |
| Q30439134 | Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. |
| Q30417509 | Cooperative binding of KLF4, pELK-1, and HDAC2 to a G/C repressor element in the SM22α promoter mediates transcriptional silencing during SMC phenotypic switching in vivo |
| Q27311289 | Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells That Contribute to the Fibrous Cap |
| Q30279158 | Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap |
| Q42371429 | Corrigendum: KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis |
| Q30413049 | Critical role of TNF-α in cerebral aneurysm formation and progression to rupture |
| Q39904340 | Derivation of contractile smooth muscle cells from embryonic stem cells. |
| Q30417984 | Detection of histone modifications at specific gene loci in single cells in histological sections |
| Q30306023 | Development of a smooth muscle-targeted cre recombinase mouse reveals novel insights regarding smooth muscle myosin heavy chain promoter regulation. |
| Q41474291 | Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation |
| Q30460194 | Differential effect of platelet-derived growth factor- versus serum-induced growth on smooth muscle alpha-actin and nonmuscle beta-actin mRNA expression in cultured rat aortic smooth muscle cells |
| Q30472866 | Early plus delayed hirudin reduces restenosis in the atherosclerotic rabbit more than early administration alone: potential implications for dosing of antithrombin agents |
| Q30468424 | Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits |
| Q30442965 | Elements of the smooth muscle alpha-actin promoter required in cis for transcriptional activation in smooth muscle. Evidence for cell type-specific regulation |
| Q28085153 | Epigenetic Control of Smooth Muscle Cell Identity and Lineage Memory |
| Q36449063 | Excitation-transcription coupling in arterial smooth muscle. |
| Q30470081 | Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements |
| Q30433885 | Forced expression of myocardin is not sufficient for induction of smooth muscle differentiation in multipotential embryonic cells |
| Q100516888 | Genetic Regulation of Atherosclerosis-Relevant Phenotypes in Human Vascular Smooth Muscle Cells |
| Q30414961 | Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation |
| Q30429015 | Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice |
| Q63915751 | Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice |
| Q54502831 | Hyperplastic growth response of vascular smooth muscle cells following induction of acute hypertension in rats by aortic coarctation. |
| Q30355344 | Inhibition of interleukin-1β decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysms. |
| Q30471257 | Interaction of CArG elements and a GC-rich repressor element in transcriptional regulation of the smooth muscle myosin heavy chain gene in vascular smooth muscle cells |
| Q56340944 | Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice |
| Q30421700 | Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms |
| Q56334440 | Irradiation abolishes smooth muscle investment into vascular lesions in specific vascular beds |
| Q100546201 | KLF4 (Kruppel-Like Factor 4)-Dependent Perivascular Plasticity Contributes to Adipose Tissue inflammation |
| Q30410765 | KLF4 regulates abdominal aortic aneurysm morphology and deletion attenuates aneurysm formation |
| Q45067616 | KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis |
| Q30299921 | KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis |
| Q30435516 | Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. |
| Q28579612 | Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids |
| Q30433980 | L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. |
| Q30439147 | LPP expression during in vitro smooth muscle differentiation and stent-induced vascular injury |
| Q30304454 | Local adenovirus-mediated delivery of hirudin in a rabbit arterial injury model |
| Q30415442 | Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation |
| Q30433459 | Lost in transdifferentiation. |
| Q30442406 | Mass spectrometric identification of phosphorylation sites of rRNA transcription factor upstream binding factor |
| Q30449270 | Mechanisms of angiotensin II- and arginine vasopressin-induced increases in protein synthesis and content in cultured rat aortic smooth muscle cells. Evidence for selective increases in smooth muscle isoactin expression |
| Q30438261 | Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells |
| Q30435971 | Molecular determinants of vascular smooth muscle cell diversity |
| Q30306339 | Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. |
| Q30470362 | Molecular regulation of smooth muscle cell differentiation. |
| Q30441514 | Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells |
| Q30312218 | Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin |
| Q30310712 | Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes |
| Q29347238 | Myocardin is differentially required for the development of smooth muscle cells and cardiomyocytes |
| Q30434723 | Myosin light chain kinase knockout |
| Q30467899 | Native and activated forms of alpha 2-macroglobulin increase expression of platelet-derived growth factor alpha-receptor in vascular smooth muscle cells. Evidence for autocrine transforming growth factor-beta activity |
| Q90908931 | Novel Autoimmune IgM Antibody Attenuates Atherosclerosis in IgM Deficient Low-Fat Diet-Fed, but Not Western Diet-Fed Apoe-/- Mice |
| Q46757550 | Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice |
| Q30465020 | Nuclear proteins bind a cis-acting element in the smooth muscle alpha-actin promoter |
| Q30277876 | Origin of Matrix-Producing Cells That Contribute to Aortic Fibrosis in Hypertension |
| Q79365777 | Origin of neointimal smooth muscle: we've come full circle |
| Q30435622 | Over-expression of the transcription factor, ZBP-89, leads to enhancement of the C2C12 myogenic program |
| Q30444292 | Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro |
| Q30436774 | Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration |
| Q30437153 | PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns |
| Q28569320 | PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins. |
| Q30427433 | PIAS1 mediates TGFbeta-induced SM alpha-actin gene expression through inhibition of KLF4 function-expression by protein sumoylation |
| Q28594760 | PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. |
| Q28505500 | Pitx2 is functionally important in the early stages of vascular smooth muscle cell differentiation |
| Q91506735 | PlaqOmics Leducq Fondation Trans-Atlantic Network |
| Q44980179 | Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells |
| Q30432867 | Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes |
| Q44923453 | Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters |
| Q30311540 | Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation |
| Q30455733 | Platelet-derived growth factor-induced destabilization of smooth muscle alpha-actin mRNA. |
| Q30305991 | Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. |
| Q52529960 | Predictors of luminal narrowing by neointima after angioplasty in atherosclerotic rabbits. |
| Q30443716 | Programming smooth muscle plasticity with chromatin dynamics |
| Q45048571 | Reconciling Smooth Muscle Cell Oligoclonality and Proliferative Capacity in Experimental Atherosclerosis |
| Q40800314 | Recruitment of serum response factor and hyperacetylation of histones at smooth muscle-specific regulatory regions during differentiation of a novel P19-derived in vitro smooth muscle differentiation system |
| Q30303899 | Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions |
| Q45011932 | Response to letter regarding article, "Inhibition of interleukin-1β decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysm". |
| Q90271733 | Revealing the Origins of Foam Cells in Atherosclerotic Lesions |
| Q30464339 | Reversible permeabilization. A novel technique for the intracellular introduction of antisense oligodeoxynucleotides into intact smooth muscle |
| Q28203628 | Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells |
| Q30253052 | Shifting the Focus of Preclinical, Murine Atherosclerosis Studies From Prevention to Late-Stage Intervention |
| Q30304262 | Similarities and differences in smooth muscle alpha-actin induction by TGF-beta in smooth muscle versus non-smooth muscle cells |
| Q30431496 | Smooth and cardiac muscle-selective knock-out of Kruppel-like factor 4 causes postnatal death and growth retardation |
| Q30304678 | Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex |
| Q30310714 | Smooth muscle alpha-actin gene requires two E-boxes for proper expression in vivo and is a target of class I basic helix-loop-helix proteins |
| Q30418243 | Smooth muscle cell phenotypic switching in atherosclerosis |
| Q30411230 | Smooth muscle cell plasticity: fact or fiction? |
| Q30252988 | Smooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions |
| Q30444477 | Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression |
| Q30306237 | Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization |
| Q30439447 | Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca2+ and decreased cGMP-induced relaxation |
| Q30434473 | Smooth muscle phenotypic modulation is an early event in aortic aneurysms |
| Q30472036 | Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5'-flanking and first intronic DNA sequence |
| Q30443089 | Smooth muscle-targeted knockout of connexin43 enhances neointimal formation in response to vascular injury |
| Q30436555 | Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle |
| Q30440617 | Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype |
| Q40347198 | Stem cells and their derivatives can bypass the requirement of myocardin for smooth muscle gene expression |
| Q30471918 | Substitution of the degenerate smooth muscle (SM) alpha-actin CC(A/T-rich)6GG elements with c-fos serum response elements results in increased basal expression but relaxed SM cell specificity and reduced angiotensin II inducibility |
| Q30410453 | TNF-α induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology |
| Q45069046 | The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology |
| Q97568309 | The Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis |
| Q30434710 | The actin associated protein palladin is important for the early smooth muscle cell differentiation |
| Q30437315 | The actin-associated protein Palladin is required for development of normal contractile properties of smooth muscle cells derived from embryoid bodies |
| Q30464808 | The smooth muscle alpha-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells |
| Q30307689 | The smooth muscle myosin heavy chain gene exhibits smooth muscle subtype-selective modular regulation in vivo |
| Q30413885 | Therapeutic implications of estrogen for cerebral vasospasm and delayed cerebral ischemia induced by aneurysmal subarachnoid hemorrhage |
| Q30469144 | Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis |
| Q30449306 | Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor |
| Q30465017 | Thrombin-induced mitogenesis in cultured aortic smooth muscle cells requires prolonged thrombin exposure |
| Q30466667 | Thrombin-induced mitogenesis of vascular SMC is partially mediated by autocrine production of PDGF-AA. |
| Q44904226 | Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells. |
| Q30457213 | Tumor necrosis factor-α modulates cerebral aneurysm formation and rupture |
| Q30277316 | Vascular Smooth Muscle Cells in Atherosclerosis |
| Q42484202 | Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. |
| Q30457214 | Vascular smooth muscle cells in cerebral aneurysm pathogenesis |
| Q30426429 | WD repeat-containing protein 5, a ubiquitously expressed histone methyltransferase adaptor protein, regulates smooth muscle cell-selective gene activation through interaction with pituitary homeobox 2. |
| Q30418789 | Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels. |
| Q90724359 | ZFP148 (Zinc-Finger Protein 148) Binds Cooperatively With NF-1 (Neurofibromin 1) to Inhibit Smooth Muscle Marker Gene Expression During Abdominal Aortic Aneurysm Formation |
| Q30470186 | alpha-Thrombin induces transforming growth factor-beta1 mRNA and protein in cultured vascular smooth muscle cells via a proteolytically activated receptor |
Search more.